Clinical trial Recruiting at 1 site Observational Ages 14 to 20

Digital tool for managing liver disease in young patients

Official title: Integrated System for Patients Who Belong the Transition to Adult Services and Are Undergoing a Liver Transplant

Run by FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS · NCT06342557 · Data updated 2026-11-12

This study is testing a new digital tool to help young people with liver disease manage their care better as they transition from pediatric to adult healthcare.

Quick facts

Study typeObservational
Ages14 Years to 20 Years
SexAll
Enrollment250 (estimated)
SponsorFROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Academic / other
Locations1 site (Bergamo, MILANO)
StatusRecruiting
StartedMarch 28, 2024
Main results expectedFebruary 21, 2034
Study endsFebruary 21, 2034
Registry record updatedFebruary 27, 2026
Trial IDNCT06342557 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients aged 14 to 20 who have received or are awaiting a liver transplant and are transitioning to adult services.

Probably not a fit

Patients outside the age range of 14 to 20 or those not undergoing a liver transplant will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study is part of the MACROLIVER Project, which aims to develop a digital tool to assist patients and caregivers in managing liver disease, particularly during the transition from pediatric to adult care. The study focuses on patients aged 14 to 20 who have undergone or are awaiting liver transplants, gathering data to identify factors affecting their psychological well-being. By optimizing therapy and treatment processes remotely, the tool seeks to enhance access to care while minimizing the need for patient travel. The study will also collect retrospective data to provide a comprehensive clinical-psychological picture of these patients.

Why it matters

Potential benefit: If successful, this study could improve the management and psychological support for young liver transplant patients during their transition to adult care.

How similar studies have gone: While this approach is innovative in its specific focus on the transition from pediatric to adult care, similar digital health interventions have shown promise in other areas of chronic disease management.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* patients between the ages of 14 and 20 who have been transplanted at the ASST-PG23 transplant center or are awaiting a liver transplant and belong to the transition to adult services
* signed informed consent
* proven use of the APPs (to be assessed based on the last 2 weeks)

Exclusion Criteria:

\-

Where it's running

  • ASST-Papa Giovanni XXIII
    Bergamo, Milano, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.